37 related articles for article (PubMed ID: 17160935)
1. Telomeres in glioma: Maintenance mechanisms to therapeutic potential.
Stevers NO; Costello JF
Neuro Oncol; 2024 Jun; 26(6):1025-1026. PubMed ID: 38466631
[No Abstract] [Full Text] [Related]
2. Suramin increased telomerase activity in the c6 glioma/wistar experimental brain tumor model.
Ergüven M; Bilir A; Altug T; Aktar F; Akev N
Int J Biomed Sci; 2007 Jun; 3(2):104-11. PubMed ID: 23675031
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of combination gene therapy with PTEN and antisense hTERT for malignant glioma in vitro and xenografts.
You Y; Geng X; Zhao P; Fu Z; Wang C; Chao S; Liu N; Lu A; Gardner K; Pu P; Kong C; Ge Y; Judge SI; Li QQ
Cell Mol Life Sci; 2007 Mar; 64(5):621-31. PubMed ID: 17310280
[TBL] [Abstract][Full Text] [Related]
4. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
5. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53.
Komata T; Kondo Y; Koga S; Ko SC; Chung LW; Kondo S
Gene Ther; 2000 Dec; 7(24):2071-9. PubMed ID: 11223987
[TBL] [Abstract][Full Text] [Related]
7. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
8. [Study on combined gene therapy for malignant gliomas transfected with antisense hTERT/PTEN in vitro and in vivo].
You YP; Fu Z; Zhao P; Wang CZ; Liu N; Lu AL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Dec; 23(6):605-9. PubMed ID: 17160935
[TBL] [Abstract][Full Text] [Related]
9. Telomerase as a therapeutic target for malignant gliomas.
Komata T; Kanzawa T; Kondo Y; Kondo S
Oncogene; 2002 Jan; 21(4):656-63. PubMed ID: 11850793
[TBL] [Abstract][Full Text] [Related]
10. [Gene therapy for brain tumors--present conditions and prospects].
Nakahara N; Yoshida J
Gan To Kagaku Ryoho; 2005 Apr; 32(4):458-62. PubMed ID: 15853210
[TBL] [Abstract][Full Text] [Related]
11. [Application of antisense human telomerase RNA toward cancer therapy].
Naka K; Yokozaki H; Tahara H; Tahara E
Nihon Rinsho; 1998 May; 56(5):1131-5. PubMed ID: 9613109
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
